Woodcock E A
Cellular Biochemistry Laboratory, Baker Medical Research Institute, Prahran, Melbourne, Australia.
J Mol Med (Berl). 1995 Jun;73(6):313-23. doi: 10.1007/BF00231618.
Numerous studies have addressed various aspects of inositol phosphate release and metabolism in myocardial preparations, and many different viewpoints have been expressed. The various results and interpretations presented often appear confusing and extracting a consensus view can be difficult. The differences often derive from the differing cardiac preparations used, especially isolated cells versus intact tissue. Despite these problems there are aspects where consensus prevails. Both the metabolism and the functional activity of inositol phosphates in heart appear to differ from those previously described in non-excitable cells. Inositol phosphates do not appear to be of major importance in the control of cardiac function under physiological conditions but may well have greater influence under pathological conditions such as myocardial ischaemia and reperfusion. Hopefully, the near future will see remaining controversies resolved.
许多研究探讨了心肌制剂中肌醇磷酸释放和代谢的各个方面,并表达了许多不同的观点。所呈现的各种结果和解释往往显得令人困惑,很难提炼出一种共识观点。这些差异通常源于所使用的不同心脏制剂,特别是分离的细胞与完整组织。尽管存在这些问题,但在某些方面仍存在共识。心脏中肌醇磷酸的代谢和功能活性似乎与先前在非兴奋性细胞中描述的有所不同。在生理条件下,肌醇磷酸在心脏功能控制中似乎并不重要,但在诸如心肌缺血和再灌注等病理条件下可能会有更大影响。希望在不久的将来,剩下的争议能够得到解决。